|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Change in right-of-use assets | |||||
| Depreciation | |||||
| Amortization of intangible | |||||
| Change in contingent consideration | |||||
| Change in fair value of equity securities | |||||
| Deferred income taxes | |||||
| Amortization of debt finance costs | |||||
| Provision for current expected credit losses | |||||
| Gain on liquidation of foreign entity | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in account receivables | |||||
| Increase in inventory | |||||
| Increase in prepaid expenses and other current assets | |||||
| (Decrease) Increase in accounts payable | |||||
| Increase in accrued expenses | |||||
| Decrease in operating lease liabilities | |||||
| Payment of contingent liability | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Investment in equity securities | |||||
| Purchase of short-term investments | |||||
| Maturity of short-term investments | |||||
| Purchase of equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from sale of common stock from public offering, net | |||||
| Proceeds from sale of common stock from at-the-market program, net | |||||
| Proceeds from public offering of common stock and pre-funded warrants, net | |||||
| Payment of employee withholding taxes on vested restricted stock units | |||||
| Proceeds from exercise of pre-funded warrants | |||||
| Proceeds from exercise of stock options | |||||
| Payment of debt issuance costs associated with the convertible notes | |||||
| Payment of contingent consideration liabilities | |||||
| ROU financing lease fees | |||||
| Net cash provided by financing activities | |||||
| Foreign exchange effects on cash | |||||
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH – BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH – END OF YEAR | |||||
| Cash paid for interest | |||||
| Supplemental Disclosure of Non-Cash, Investing, and Financing Activities: | |||||
| Liability related to license agreement | |||||
| Unpaid debt issuance costs associated with the convertible notes | |||||
| Issuance of common stock for Melinta acquisition | |||||
| Fair value of contingent payments | |||||
| ROU assets and liabilities for finance lease | |||||
| Fair value of assets acquired from Melinta | |||||
| Liabilities assumed from Melinta | |||||
| Goodwill recognized on Melinta | |||||
Loading...